NFKB1 and left ventricular hypertrophy: These molecules possess anti-inflammatory capacity, inhibiting the NF-kB pathway, and they have been shown to reduce arterial pressure [64] and participate in the inhibition of mechanisms implicated in the generation of left ventricular hypertrophy and myocardial fibrosis [65].